CV Dr. med. Beate Gleissner
Specialisation Internal Medicine, Haematology, Medical Oncology, FMH

Working Experience

Private Practise in Rapperswil since 2009, in Bäch since 2010, and in Dietikon since 2016

In-patient physician Clinic im Park-Zürich, Spital Einsiedeln


Haematological and Oncological Consultant, Spital Lachen

Haematological and Oncological Consultant,  ZeTuP, Tumorzentrum St. Gallen

Haematological and Oncological Consultant, Deputy of senior physician, Medical Clinic I, Clinic for Haematology, Oncology, Rheumatology, and Infectious Diseases, University Hospital Homburg, Saarland, Germny
Head of Clinical Trial Center, Consultant Central Trial Center fo the German High Grade Lymphome Study Group, Head of the interdisciplinary Center for Chemotherapies

Haematological and Oncological Consultant, Medical Clinic III, Haematology, Oncology, Transfusion Medicine, Campus Benjamin Franklin, Charitê, Berlin
Head of the molecular genetic diagnostics laboratory, central diagnostic laboratory of the GMALL, German Adult ALL Study Group

Scientific Assistant, Medical Clinic III, Haematology, Oncology, Transfusion Medicine, Clinicum Steglitz, renamed Campus Benjamin Franklin, Charitê, Berlin

Assistenzärztin an der Medizinisch Klinik, Klinikum Hof, Lehrkrankenhaus der Universität Erlangen-Nürnberg

Molekulargenetische Risikostratifizierung  der Erwachsenen ALL,
Medizinische Klinik III, Prof. Thiel, Charitê




Study of Human Medicine at the  University Erlangen-Nuernberg

Study of Protein Polymorphism of Class-III Antigens C2, Bf and C4 in patients with Masthenia gravis
Clinic for clinical Immunology and Rheumatology, Prof. Kalden, University Erlangen-Nuernberg



Original papers

Hess S., Pfreundschuh M, Gleissner B. Notch signaling. J Neuro-Surg, 2007; 107(5):1060-1.

Gleissner B, Chamberlain MC. Treatment of CNS dissemination in systemic lymphoma. J Neuro-Oncology 2007; 5(5):443-452,

Pagano L, Gleissner B, Fianchi L. Breakthrough zygomycosis and voriconazole. Journal of Infectious Diseases, 2005; 192: 1496-7.

Gleissner B, Goekbuget N, Rieder H, Schwartz S, Diedrich H, Arnold R, Schoch C, Heinze B, Fonatsch C, Bartram CR, Hoelzer D, Thiel E, for the GMALL Study Group. CD10-negative pre-B acute lymphoblastic leukemia (ALL): a distinct high-risk subgroup of adult ALL. Results of the German Multicenter Trials for Adult ALL (GMALL). Blood, 2005: 106: 4054-6.

Gleissner B, Schilling A, Anagnostopopoulos I, Siehl J, Thiel E. Improved outcome of zygomycosis in patients with hematological diseases? Leukemia & Lymphoma 2004; 45(7): 1351-1360.

Gleissner B, Goekbuget N, Bartram CR, Janssen B, Rieder H, Janssen JWG, Fonatsch C, Heyll A, Voliotis D, Beck J, Lipp T, Munzert G, Maurer J, Hoelzer D, Thiel E, the GMALL study group. Leading prognostic relevance of the BCR-ABL translocation in adult acute B-lineage lymphoblastic leukemia: a prospective study by confirmed polymerase chain reaction (PCR) analysis of the German Multicenter Trial Group.

Blood 2002;99(5):1536-1543.

Gleissner B, Siehl J, Korfel A, Reinhardt R, Thiel E. CSF evaluation in primary CNS lymphoma patients by PCR of the CDR III IgH genes. Neurology 2002; 58(3): 390-396.

Gleissner B, Blau IW, Sindram A, Reinhardt R, Knauf W, Thiel E. Analysis of chimerism during the early period after allogeneic peripheral stem cell transplantation. Clinical & Laboratory Haematolgy 2001; 23: 401-406.


Gleissner B, Rieder H, Thiel E, Fonatsch Ch, Janssen LAJ, Heinze B, Janssen JWG, Schoch C, Goekbuget N, Maurer J, Hoelzer D, Bartram CR. Prospective BCR-ABL analysis by polymerase chain reaction (RT-PCR) in adult acute B-lineage lymphoblastic leukemia: reliability of RT-nested-PCR and comparison to cytogenetic data. Leukemia 2001;15: 1834-1840.

Gleissner B, Maurer J, Sindram A, Reinhardt R, Thiel E. Comparison of ethidium bromide-stained agarose gel electrophoresis and automated fragment analysis for evaluation of IgH gene products. Leukemia Research 2001; 25: 796-774

Gleissner B, Maurer J, Thiel E. Detection of immunoglobulin heavy chain genes rearrangements in B-cell leukemias, lymphomas, multiple myelomas, monoclonal and polyclonal gammopathies. Leukemia & Lymphoma 2000; 39(1/2): 151-155.

Gleissner B, Hellmann A, Berdel WE, Edler L, Koldehoff M, Rost A, Opri F, Fritze D, Öhl S. Phase I/II study of paclitaxel and 5-fluorouracil as second-line therapy in patients with metastatic breast cancer. Onkologie 1998; 21: 305-308.

Wadler S, Gleissner B, Hilgenfeld RU, Thiel E, Hayner H, Kaleya R, Rozenblit A, Kreuser E.D. Phase II study of N-(phosphonacetyl)-L-aspartate (PALA), 5-fluorouracil and recombinant interferon α-2b in patients with advanced gastric carcinoma. European Journal of Cancer 1996; 324(7): 1254-1256.

Kölble K, Gleissner B, Diepgen T, Stöcker W, Mohr C, Kalies I, Druschky K-F, Kalden JR. Complotypes of the major histocompatibility complex linked class III genes in Myasthenia gravis. Annals New York Academy of Science 1987; 505: 792-796. Impact Faktor: 1,789.



Schilling A, Seibold M, Mansman V, Gleissner B. Successfully treated Candida krusei infection of the lumbar spine with combined caspofungin/posaconazole therapy. Med. Mycol 2008;46(1):79-83.

Mailander V, Gleissner B, Blau I, Thiel E. Guillain-Barre-Strohl syndrome unraveled as paraneoplastic syndrome of B-cell acute lymphoblastic leukemia in a patient with preceding common variable immunodeficiency syndrome with Evans syndrome. Leukemia & Lymphoma 2004; 45(1):189-92..




Gleissner B., Zwick C, Pfreundschuh M. Behandlung diffus großzelliger Non-Hodgkin Lymphom. Deutsche Medizinische Wochenschrift, 2008

Zwick C, Gleissner B, Pfreundschuh M. Aspects of chemotherapy schedules in young and elderly patients with aggressive lymphoma. Clin Lymphoma Myeloma 2007; 8(2):43-9.

Gleissner B, Küppers M, Siebert R, et al. Report on a workshop on malignant lymphoma: a review of molecular and clinical risk profiling. Brit J Haematology, 2008, Epub ahead,

Gleissner B, Zwick C, Pfreundschuh M. Treatment of aggressive lymphomas. Internist, 2007, 48(4):389-95.

Gleissner B, Schlenk R, Bornhäuser M, Berdel WE. Gemtuzumab ozogamicin (mylotarg) for the treatment of acute myeloid leukemia-ongoing trials. Onkologie 2007; 30(12): 657-62.

Thiel E, Gleissner B. Meningeosis neoplastica, Deutsches Ärzteblatt, 2006; 39: 2559-2565.

Gleissner B, Chamberlain MC. Meningeosis neoplastica. Lancet Neurology 2006; 5(5):443-452,

Gleissner B, Hoelzer D, Thiel E. Therapie der Meningeosis neoplastica. journalONKOLOGIE 2005; 4, 40-46.

Gleissner B, Thiel E. Molecular genetic events in adult acute lymphoblastic leukemia. Expert Review of Molecular Diagnostics 2003; 3(3): 89-105.

Gleissner B, Thiel E. Detection of immunoglobulin heavy chain (IgH) gene rearrangements in hematologic malignancies. Expert Review of Molecular Diagnostics 2001; 1(2): 191-2001.


Gleissner B. Myelodysplasie und Chronisch Myeloische Leukämie in Entscheidungsprozesse Innere Medizin, Hrsg. Brunkhorst, Schölmerich, in press

Gleissner B, Pfreundschuh M. Akute Leukämien. In Compedium Onkologie, Herausgeber Preiss, 2008.

Gleissner B, Pfreundschuh M. Therapeutische Ansätze zur Behandlung hochmaligner Lymphoma. Colloquium Onkologie, 2007.

Gleissner B., Zwick C., Pfreundschuh M. Therapie aggressiver Lymphome, In „Lymphomtherapie“, Herausgeber Rummel, Reihe UniMed Verlag, 2007.

Thiel E, Gleissner B. Ätiologie und Pathogenese. In Akute lymphatische Leukämie des Erwachsenen. Reihe UNI-MED Verlag, 2007.

Gleissner B, Bartram CR, Rieder H, Janssen LAJ, Janssen JWG, Goekbuget N, Hoelzer D, Fonatsch C, Heinze B, Schoch C, Thiel E. Reliability of BCR-ABL RT_PCR in adult acute B-lineage lymphoblastic leukemia: results of confirmatory PCR. In Acute Leukemia IX, Hiddemann W, Büchner T, Ritter J, Unterhalt M, Haferlach T (Eds.) Springer Verlag, 2003:338-341.

  • American Society of Oncology
  • American Society of Hematology
  • Deutsche Gesellschaft für Hämatologie
  • European Society of Medical Oncology